Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim F Greten

Showing results (31-40 of 222) with videos related to

Pageof 23
Sort By:
Hepatology (Baltimore, Md.)|April 2, 2022
Innate lymphoid cells at the crossroads of innate and adaptive immunityFirouzeh Korangy, Bernd Heinrich, Tim F Greten
Nature Reviews. Cancer|April 20, 2023
Innate lymphoid cells and innate-like T cells in cancer - at the crossroads of innate and adaptive immunityBenjamin Ruf, Tim F Greten, Firouzeh Korangy
Cellular & Molecular Immunology|November 25, 2020
Immunobiology and immunotherapy of HCC: spotlight on innate and innate-like immune cellsBenjamin Ruf, Bernd Heinrich, Tim F Greten
Hepatology (Baltimore, Md.)|November 1, 2012
Hemorrhagic events in hepatocellular carcinoma patients treated with antiangiogenic therapiesAustin Duffy, Julia Wilkerson, Tim F Greten
International Journal of Cancer|August 30, 2012
Prognostic value of cetuximab-related skin toxicity in metastatic colorectal cancer patients and its correlation with parameters of the epidermal growth factor receptor signal transduction pathway: results from a randomized trial of the GERMAN AIO CRC Study GroupAustin Duffy, Osama Rahma, Tim F Greten
Cellular Immunology|January 28, 2021
MDSCs in liver cancer: A critical tumor-promoting player and a potential therapeutic targetChi Ma, Qianfei Zhang, Tim F Greten
The FEBS Journal|September 1, 2017
Nonalcoholic fatty liver disease promotes hepatocellular carcinoma through direct and indirect effects on hepatocytesChi Ma, Qianfei Zhang, Tim F Greten
Cellular and Molecular Life Sciences : CMLS|October 3, 2014
Immunogenicity of necrotic cell deathJaba Gamrekelashvili, Tim F Greten, Firouzeh Korangy
Digestive Diseases (Basel, Switzerland)|October 31, 2012
Cellular immune suppressor mechanisms in patients with hepatocellular carcinomaFei Zhao, Firouzeh Korangy, Tim F Greten
Cancer|January 24, 2023
Top advances of the year: Hepatobiliary cancersKelley L Coffman-D'Annibale, Tim F Greten
Pageof 23

Showing results (31-40 of 222) with videos related to

Sort By:
Pageof 23
Hepatology (Baltimore, Md.)|April 2, 2022
Innate lymphoid cells at the crossroads of innate and adaptive immunityFirouzeh Korangy, Bernd Heinrich, Tim F Greten
Nature Reviews. Cancer|April 20, 2023
Innate lymphoid cells and innate-like T cells in cancer - at the crossroads of innate and adaptive immunityBenjamin Ruf, Tim F Greten, Firouzeh Korangy
Cellular & Molecular Immunology|November 25, 2020
Immunobiology and immunotherapy of HCC: spotlight on innate and innate-like immune cellsBenjamin Ruf, Bernd Heinrich, Tim F Greten
Hepatology (Baltimore, Md.)|November 1, 2012
Hemorrhagic events in hepatocellular carcinoma patients treated with antiangiogenic therapiesAustin Duffy, Julia Wilkerson, Tim F Greten
International Journal of Cancer|August 30, 2012
Prognostic value of cetuximab-related skin toxicity in metastatic colorectal cancer patients and its correlation with parameters of the epidermal growth factor receptor signal transduction pathway: results from a randomized trial of the GERMAN AIO CRC Study GroupAustin Duffy, Osama Rahma, Tim F Greten
Cellular Immunology|January 28, 2021
MDSCs in liver cancer: A critical tumor-promoting player and a potential therapeutic targetChi Ma, Qianfei Zhang, Tim F Greten
The FEBS Journal|September 1, 2017
Nonalcoholic fatty liver disease promotes hepatocellular carcinoma through direct and indirect effects on hepatocytesChi Ma, Qianfei Zhang, Tim F Greten
Cellular and Molecular Life Sciences : CMLS|October 3, 2014
Immunogenicity of necrotic cell deathJaba Gamrekelashvili, Tim F Greten, Firouzeh Korangy
Digestive Diseases (Basel, Switzerland)|October 31, 2012
Cellular immune suppressor mechanisms in patients with hepatocellular carcinomaFei Zhao, Firouzeh Korangy, Tim F Greten
Cancer|January 24, 2023
Top advances of the year: Hepatobiliary cancersKelley L Coffman-D'Annibale, Tim F Greten
Pageof 23